DOCSLIB.ORG

Adverse Events of Upper GI Endoscopy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Adverse Events of Upper GI Endoscopy GUIDELINE Adverse events of upper GI endoscopy This is one of a series of statements discussing the use of lications rely on self-reporting, and most reported data GI endoscopy in common clinical situations. The Stan- collected only from the immediate periprocedure period, dards of Practice Committee of the American Society for thus the rate of late adverse events and mortality may be Gastrointestinal Endoscopy (ASGE) prepared this text. underestimated.8,9 Major adverse events related to diag- In preparing this document, a search of the medical liter- nostic UGI endoscopy are rare and include cardiopulmo- ature was performed by using PubMed. Additional refer- nary adverse events, infection, perforation, and bleeding. ences were obtained from the bibliographies of the identi- Adverse events of ERCP and EUS are discussed in separate fied articles and from recommendations of expert ASGE documents.10,11 consultants. When few or no data exist from well-designed prospective trials, emphasis is given to results of large series and reports from recognized experts. This document is ADVERSE EVENTS ASSOCIATED WITH based on a critical review of the available data and expert DIAGNOSTIC UGI ENDOSCOPY consensus at the time that the document was drafted. Further controlled clinical studies may be needed to clar- Cardiopulmonary adverse events ify aspects of this document. This document may be re- Most UGI procedures in the United States and Europe vised as necessary to account for changes in technology, are performed with patients under sedation (moderate or 12 new data, or other aspects of clinical practice. deep). Cardiopulmonary adverse events related to seda- This document is intended to be an educational device tion and analgesia account for as much as 60% of UGI 1-4,7 to provide information that may assist endoscopists in endoscopy adverse events. The rate of cardiopulmo- providing care to patients. This document is not a rule and nary adverse events in large, national studies is between 1 1-4,6,7 should not be construed as establishing a legal standard of in 170 and 1 in 10,000. Reported adverse events range care or as encouraging, advocating, requiring, or discour- from minor incidents, such as changes in oxygen satura- aging any particular treatment. Clinical decisions in any tion or heart rate, to significant adverse events such as particular case involve a complex analysis of the patient’s aspiration pneumonia, respiratory arrest, myocardial in- condition and available courses of action. Therefore, clin- farction, stroke, and shock. Patient-related risk factors for ical considerations may lead an endoscopist to take a cardiopulmonary adverse events include preexisting course of action that varies from this document. cardiopulmonary disease, advanced age, American So- ciety of Anesthesiologists class III or higher, and an Upper GI (UGI) endoscopy is commonly performed increased modified Goldman score.13,14 Procedure- and carries a low risk of adverse events. Large series report related risk factors for hypoxemia include difficulty with adverse event rates of 1 in 200 to 1 in 10,000 and mortality intubating the esophagus, a prolonged procedure, and a rates ranging from none to 1 in 2000.1-6 Data collected patient in the prone position.7,8,15,16 For a detailed dis- from the Clinical Outcomes Research Initiative database cussion and specific recommendations, the reader is show a cardiopulmonary event rate of 1 in 170 and a referred to the ASGE document “Sedation and Anesthe- mortality rate of 1 in 10,000 from among 140,000 UGI sia in GI Endoscopy”17 and the “American Society of endoscopic procedures.7 The variability in rates of adverse Anesthesiology Practice Guidelines for Sedation and events may be attributed to the method of data collection, Analgesia by Nonanesthesiologists.”18 patient populations, duration of follow-up, and definitions of adverse events. Some authors include minor incidents, such as transient hypoxemia or self-limited bleeding as Infectious adverse events adverse events, whereas others report only significant ad- Infectious adverse events of diagnostic UGI endoscopy verse events that prevent completion of the procedure or can result from either the procedure itself or failure to result in hospitalization.8 Additionally, the majority of pub- follow guidelines for the reprocessing and use of endo- scopic devices and accessories.19,20 Transient bacteremia as a result of diagnostic UGI endoscopy has been reported at rates as high as 8%, but the frequency of infectious Copyright © 2012 by the American Society for Gastrointestinal Endoscopy 0016-5107/$36.00 endocarditis and other clinical sequelae is extremely 21,22 http://dx.doi.org/10.1016/j.gie.2012.03.252 low. Current American Heart Association and ASGE guidelines do not recommend antibiotic prophylaxis with www.giejournal.org Volume 76, No. 4 : 2012 GASTROINTESTINAL ENDOSCOPY 707 Adverse events of upper GI endoscopy diagnostic UGI endoscopy solely to prevent infectious propriate, placement of an endotracheal tube for airway endocarditis.20,23 protection. Although the incidence of bacteremia with UGI dilation ranges from 12% to 22%, infectious sequelae Perforation are rare.47 Therefore, antibiotic prophylaxis is not Prospective, multicenter registries report perforation recommended.20 rates of 1 in 2500 to 1 in 11,000.4,24 Factors predisposing to Dilation of esophageal strictures. The most com- perforation include the presence of anterior cervical os- mon adverse events of esophageal dilation are perforation teophytes, Zenker’s diverticulum, esophageal stricture, and bleeding. Wire-guided bougie dilation or through-the- malignancies of the UGI tract, and duodenal divertic- scope balloon dilation may have lower risks of adverse ula.24,25 Perforation of the esophagus is associated with a events than blind passage of dilators.42 Randomized trials mortality rate between 2% and 36%.26-29 Early identifica- suggest that wire-guided polyvinyl dilators and through- tion and expeditious management of a perforation have the-scope balloons have similar rates of both efficacy and been shown to decrease associated morbidity and adverse events.41,44,48,49 mortality.29,30 The rate of perforation after esophageal dilation for esophageal rings and simple peptic strictures is lower than Bleeding that of certain high-risk lesions. Dilation of complex stric- Clinically significant bleeding is a rare adverse event of tures (angulated, multiple, or long) with Maloney dilators diagnostic UGI endoscopy.31 Mallory-Weiss tears occur in may be associated with a 2% to 10% risk of perforation50,51 less than 0.5% of diagnostic UGI endoscopic procedures so wire-guided or balloon dilation is likely a safer alterna- and usually are not associated with significant bleeding.32 tive.42 Dilation of caustic strictures, which tend to be long Bleeding may be more likely in individuals with thrombo- and angulated, is associated with a higher rate of adverse cytopenia and/or coagulopathy.1 The minimum threshold events.52,53 Dilation of eosinophilic esophagitis is associ- platelet count for the performance of diagnostic UGI en- ated with a high incidence of mucosal tears, but only 1 doscopy has not been established. UGI endoscopy with perforation was identified in a systematic review of 671 biopsy was shown to be safe in 1 study of adults with solid dilations for eosinophilic esophagitis.54 The risk of perfo- malignancies and platelet counts greater than 20,000/mL.33 ration resulting from dilation of malignant strictures of the Two case series of UGI endoscopy with or without biop- esophagus is approximately 10%55,56 and is associated sies in children with platelet counts greater than with increasing dilator diameter.56-59 Radiation-induced 50,000/mL reported no bleeding adverse events.34,35 How- strictures have also been reported to have a high rate of ever, a larger study of 198 UGI endoscopies in children dilation-related adverse events,60 but this risk may be re- after stem cell transplantation demonstrated that the risk of lated to the presence of malignancy rather than the effect bleeding requiring red blood cell transfusions after UGI of radiation.61 endoscopic biopsies was 4% despite a minimum platelet Pain is the most common symptom related to perfora- count of 50,000/mL.36 Four of these 8 patients were found tion.25,26,62,63 Fever, crepitus, pleuritic chest pain, leukocy- to have duodenal hematomas. Thus, some authors have tosis, and pleural effusion may also be present. Perforation concluded that diagnostic UGI endoscopy can be per- with associated air dissection may be diagnosed by plain formed when the platelet level is 20,000/mL or greater and radiography of the neck and/or chest, but such findings that a threshold of 50,000/mL should be considered before may be absent immediately after perforation.64 If a perfo- performing biopsies.37-40 ration is suspected, contrast esophagography should be performed, usually beginning with water-soluble con- ADVERSE EVENTS OF ENDOSCOPIC trast.65 If the site of perforation cannot be determined but INTERVENTIONS suspicion remains high, a barium esophagram or CT scan of the chest is indicated. A CT scan with oral contrast is Adverse events of UGI dilation sensitive for the site of perforation and for more subtle Data from randomized trials and large case series sug- findings such as minute amounts of air or fluid.66 gest that the overall rate of dilation adverse events is The approach to the patient with perforation depends between 0.1% and 0.4%.1,41-44 The most common
Load more

Recommended publications
  • Laparoscopic Heller's Cardiomyotomy in Cirrhosis with Oesophageal Varices
    Unusual Case Laparoscopic Heller’s cardiomyotomy in cirrhosis with oesophageal varices Abhay N Dalvi, Pinky M Thapar, Nitin M Narawane1, Rippan N Shukla Departments of Minimal Invasive Surgery and 1Gastroenterology, Jupiter Hospital, Thane, Maharashtra, India. Address for correspondence: Dr. Abhay N Dalvi, 257 Walkeshwar Road, Mumbai-400 006, India. E-mail: [email protected] Abstract in the presence of varices is technically challenging. Bleeding obscuring the vision is one of the obstacles Surgical intervention in cirrhosis of liver with of this procedure that can lead to complication portal hypertension is associated with increased morbidity and mortality. This is attributed to of oesophageal mucosal perforation. Thorough liver decompensation, intra-operative bleeding, pre-operative investigations, planning, meticulous prolonged operative time, wound related and dissection are required to tackle this problem by a anaesthesia complications. Laparoscopic surgery laparoscopic approach. PUBMED search shows no in cirrhosis is advantageous but is associated with reported case of laparoscopic cardiomyotomy in patient technical challenges. We report one such case of cirrhosis with oesophageal varices. of hepatitis C cirrhosis with oesophageal varices and symptomatic achalasia cardia, who was successfully treated by laparoscopic cardiomyotomy CASE REPORT after thorough preoperative workup and planning. In the review of literature on pubmed, no such case A 53-year-old lady was referred to us for surgical is reported.. management of achalasia cardia. In the past, she had sustained severe gastroenteritis (30 years ago) for which Key words: Achalasia, cirrhosis, esophageal varices, laparoscopic cardiomyotomy. she was transfused 2 units of blood. She developed jaundice 25 years ago which responded to medical DOI: 10.4103/0972-9941.65164 management.
    [Show full text]
  • General Signs and Symptoms of Abdominal Diseases
    General signs and symptoms of abdominal diseases Dr. Förhécz Zsolt Semmelweis University 3rd Department of Internal Medicine Faculty of Medicine, 3rd Year 2018/2019 1st Semester • For descriptive purposes, the abdomen is divided by imaginary lines crossing at the umbilicus, forming the right upper, right lower, left upper, and left lower quadrants. • Another system divides the abdomen into nine sections. Terms for three of them are commonly used: epigastric, umbilical, and hypogastric, or suprapubic Common or Concerning Symptoms • Indigestion or anorexia • Nausea, vomiting, or hematemesis • Abdominal pain • Dysphagia and/or odynophagia • Change in bowel function • Constipation or diarrhea • Jaundice “How is your appetite?” • Anorexia, nausea, vomiting in many gastrointestinal disorders; and – also in pregnancy, – diabetic ketoacidosis, – adrenal insufficiency, – hypercalcemia, – uremia, – liver disease, – emotional states, – adverse drug reactions – Induced but without nausea in anorexia/ bulimia. • Anorexia is a loss or lack of appetite. • Some patients may not actually vomit but raise esophageal or gastric contents in the absence of nausea or retching, called regurgitation. – in esophageal narrowing from stricture or cancer; also with incompetent gastroesophageal sphincter • Ask about any vomitus or regurgitated material and inspect it yourself if possible!!!! – What color is it? – What does the vomitus smell like? – How much has there been? – Ask specifically if it contains any blood and try to determine how much? • Fecal odor – in small bowel obstruction – or gastrocolic fistula • Gastric juice is clear or mucoid. Small amounts of yellowish or greenish bile are common and have no special significance. • Brownish or blackish vomitus with a “coffee- grounds” appearance suggests blood altered by gastric acid.
    [Show full text]
  • Complication Prevention for Patients with Diabetes a Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients
    Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients Complication prevention for patients with diabetes A noncommunicable disease education manual for primary health care professionals and patients The Noncommunicable Disease Education Manual for Primary Health Care Professionals and Patients results from the contributions and hard work of many people. Its development was led by Dr Hai-Rim Shin, Coordinator, and Dr Warrick Junsuk Kim, Medical Officer, of the Noncommunicable Diseases and Health Promotion unit at the WHO Regional Office for the Western Pacific (WHO/WPRO/NCD) in Manila, Philippines. WHO graciously acknowledges the intellectual contributions of Dr Jung-jin Cho, Co-director, Community-based Primary Care Project Committee and Professor, Department of Family Medicine, Hallym University Sacred Heart Dongtan Hospital, Republic of Korea; Dr Hyejin Lee, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Family Medicine, Seoul National University, Republic of Korea); Ms Saki Narita, Volunteer, WHO/WPRO/NCD (currently PhD candidate, Department of Global Health Policy, Graduate School of Medicine, University of Tokyo, Japan); and Mr Byung Ki Kwon, Technical Officer, WHO/WPRO/NCD (currently Director, Division of Health Promotion, Ministry of Health and Welfare, Republic of Korea). Many thanks to Dr Albert Domingo, Dr Sonia McCarthy, Ms Marie Clem Carlos, Dr Katrin Engelhardt, Mr Kelvin Khow Chuan Heng and Dr Roberto Andres Ruiz from the WHO Regional Office for the Western Pacific and Dr Ma. Charina Benedicto, Physician-in-Charge, Bagong Barangay Health Center & Lying-in Clinic, Pandacan, Manila, Philippines for reviewing the draft publication. Financial support for this publication was received from the Korea Centers for Disease Control and Prevention, Republic of Korea.
    [Show full text]
  • Risk Factors and Complications in Type 2 Diabetes Outpatients
    RISKORIGINAL FACTORS AND COMPLICATIONS ARTICLE IN TYPE 2 DIABETES OUTPATIENTS Risk factors and complications in type 2 diabetes outpatients ELLEN FERNANDES FLávIO SILVA1, CRISTIANE MARIA MENDES FERREIRA2*, LUCINEIA DE PINHO3 1Medical Student, Faculdades Unidas do Norte de Minas (Funorte), Montes Claros, MG, Brazil 2Endocrinologist, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil 3PhD in Health Sciences, Unimontes and Funorte, Montes Claros, MG, Brazil SUMMARY Objective: Our study investigated type 2 diabetes mellitus (T2DM) outpatients attending a university hospital in Montes Claros, MG, to estimate the prevalence of risk factors and their association with diabetes complications. Method: This was a quantitative, documental, retrospective and analytical study. Medical records of 95 outpatients with T2DM treated in this hospital from 2011 to 2015 were analyzed. Data were collected according to a structured questionnaire surveying sociodemographic, anthropometric and biochemical data and clinical and lifestyle aspects. Regression analysis was used to evaluate the association between risk factor variables and complications. Results: With a mean age of 54 years, the study population showed irregular blood glucose control, despite the use of hypoglycemic medication, and did not Study conducted at Universidade have a healthy lifestyle. The main complication reported was high blood pressure Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil (HBP), occurring in 70.9% of patients. The prevalence of complications was positively associated with patients receiving insulin treatment (p=0.042) and Article received: 11/13/2016 Accepted for publication: 12/19/2016 multidisciplinary monitoring (p=0.050). Conclusion: The associations identified reflect the condition of patients that *Correspondence: Address: Av. Dr.
    [Show full text]
  • Editorial Has the Time Come for Cyanoacrylate Injection to Become the Standard-Of-Care for Gastric Varices?
    Tropical Gastroenterology 2010;31(3):141–144 Editorial Has the time come for cyanoacrylate injection to become the standard-of-care for gastric varices? Radha K. Dhiman, Narendra Chowdhry, Yogesh K Chawla The prevalence of gastric varices varies between 5% and 33% among patients with portal Department of Hepatology, hypertension with a reported incidence of bleeding of about 25% in 2 years and with a higher Postgraduate Institute of Medical bleeding incidence for fundal varices.1 Risk factors for gastric variceal hemorrhage include the education Research (PGIMER), size of fundal varices [more with large varices (as >10 mm)], Child class (C>B>A), and endoscopic Chandigarh, India presence of variceal red spots (defined as localized reddish mucosal area or spots on the mucosal surface of a varix).2 Gastric varices bleed less commonly as compared to esophageal Correspondence: Dr. Radha K. Dhiman, varices (25% versus 64%, respectively) but they bleed more severely, require more blood E-mail: [email protected] transfusions and are associated with increased mortality.3,4 The approach to optimal treatment for gastric varices remains controversial due to a lack of large, randomized, controlled trials and no clear clinical consensus. The endoscopic treatment modalities depend to a large extent on an accurate categorization of gastric varices. This classification categorizes gastric varices on the basis of their location in the stomach and their relationship with esophageal varices.1,5 Gastroesophageal varices are associated with varices along
    [Show full text]
  • Impairment of Nitric Oxide Pathway by Intravascular Hemolysis Plays A
    1521-0103/367/2/194–202$35.00 https://doi.org/10.1124/jpet.118.249581 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 367:194–202, November 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Impairment of Nitric Oxide Pathway by Intravascular Hemolysis Plays a Major Role in Mice Esophageal Hypercontractility: Reversion by Soluble Guanylyl Cyclase Stimulator Fabio Henrique Silva, Kleber Yotsumoto Fertrin, Eduardo Costa Alexandre, Fabiano Beraldi Calmasini, Carla Fernanda Franco-Penteado, and Fernando Ferreira Costa Hematology and Hemotherapy Center (F.H.S., K.Y.F., C.F.F.-P., F.F.C.) and Department of Pharmacology, Faculty of Medical Sciences (E.C.A., F.B.C.), University of Campinas, Campinas, São Paulo, Brazil; and Division of Hematology, University of Washington, Seattle, Washington (K.Y.F.) Downloaded from Received April 1, 2018; accepted July 30, 2018 ABSTRACT Paroxysmal nocturnal hemoglobinuria (PNH) patients display cyclase stimulator 3-(4-amino-5-cyclopropylpyrimidin-2-yl)- exaggerated intravascular hemolysis and esophageal disor- 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine (BAY 41-2272; ders. Since excess hemoglobin in the plasma causes re- 1 mM) completely reversed the increased contractile responses jpet.aspetjournals.org duced nitric oxide (NO) bioavailability and oxidative stress, we to CCh, KCl, and EFS in PHZ mice, but responses remained hypothesized that esophageal contraction may be impaired unchanged with prior treatment with NO donor sodium nitro- by intravascular hemolysis. This study aimed to analyze the prusside (300 mM). Protein expression of 3-nitrotyrosine and alterations of the esophagus contractile mechanisms in a 4-hydroxynonenal increased in esophagi from PHZ mice, sug- murine model of exaggerated intravascular hemolysis induced gesting a state of oxidative stress.
    [Show full text]
  • Diagnostic Direct Laryngoscopy, Bronchoscopy & Esophagoscopy
    Post-Operative Instruction Sheet Diagnostic Direct Laryngoscopy, Bronchoscopy & Esophagoscopy Direct Laryngoscopy: Examination of the voice box or larynx (pronounced “lair-inks”) under general anesthesia. An instrument called a laryngoscope is carefully placed into the mouth and used to visualize the larynx and surrounding structures. Bronchoscopy: Examination of the windpipe below the voice box in the neck and chest under general anesthesia. A long narrow telescope is passed through the larynx and used to carefully inspect the structures of the trachea and bronchi. Esophagoscopy: Examination of the swallowing pipe in the neck and chest under general anesthesia. An instrument called an esophagoscope is passed into the esophagus (just behind the larynx and trachea) and used to visualize the mucus membranes and surrounding structures of the esophagus. Frequently a small biopsy is taken to evaluate for signs of esophageal inflammation (esophagitis). What to Expect: Diagnostic airway endoscopy procedures generally take about 45 minutes to complete. Usually the procedure is well-tolerated and the child is back-to-normal the next day. Mild throat or tongue discomfort may persist for a few days after the procedure and is usually well-controlled with over-the-counter acetaminophen (Tylenol) or ibuprofen (Motrin). Warning Signs: Contact the office immediately at (603) 650-4399 if any of the following develop: • Worsening harsh, high-pitched noisy-breathing (stridor) • Labored breathing with chest retractions or flaring of the nostrils • Bluish discoloration of the lips or fingernails (cyanosis) • Persistent fever above 102°F that does not respond to Tylenol or Motrin • Excessive coughing or respiratory distress during feeding • Coughing or throwing up bright red blood • Excessive drowsiness or unresponsiveness Diet: Resume baseline diet (no special postoperative diet restrictions).
    [Show full text]
  • Laryngeal Endoscopy (Rigid, Flexible, and Stroboscopy)
    Laryngeal Endoscopy (Rigid, Flexible, and Stroboscopy) Visualization of the larynx can be performed via several different methods. Special tools are required for laryngeal evaluation. Mirror laryngoscopy (1) o While the patient’s tongue is protruded, a mirror is placed in the posterior oropharynx with gentle pressure on the soft palate while light is reflected caudally into the larynx. o Mirror laryngoscopy can be challenging for both the examiner and the patient, has limited magnification, and may require topical anesthesia. o Mirror laryngoscopy provides the most accurate color representation of laryngeal and pharyngeal tissue because there is no light or digital distortion. Flexible laryngoscopy (2) o A flexible laryngoscope is placed into the nasal cavity, through the naso- and oropharynx and positioned cephalad to the larynx for a full laryngeal assessment. o Nasal anesthesia (lidocaine) and/or nasal decongestants (oxymetazoline/phenylephrine) may be applied to the nose for the purpose of improving patient comfort and tolerance o Supplemental procedures such as dynamic voice assessment (comprehensive laryngeal movement evaluation), functional endoscopic evaluation of swallowing (+/- sensory testing), and other laryngeal procedures (ex. injections, laser surgery, biopsies) can be performed during flexible laryngoscopy. o Flexible laryngoscopy is ideal for evaluating vocal fold weakness, real-time/unencumbered evaluation of task-specific abnormalities (ex. my voice is problematic when I do this), and assessing the intensity of glottal attack. Rigid Laryngoscopy (3) o Rigid laryngoscopy is performed by placing a rigid 70- or 90-degree telescope into the oropharynx during tongue protrusion. o Sometimes, oropharyngeal and/or tongue application of anesthesia (ex. lidocaine, cetacaine) can be helpful for patient tolerance.
    [Show full text]
  • ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding
    nature publishing group PRACTICE GUIDELINES 1265 CME ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding L a u r e n B . G e r s o n , M D , M S c , F A C G1 , J e ff L. Fidler , MD 2 , D a v i d R . C a v e , M D , P h D , F A C G 3 a n d J o n a t h a n A . L e i g h t o n , M D , F A C G 4 Bleeding from the small intestine remains a relatively uncommon event, accounting for ~5–10% of all patients presenting with gastrointestinal (GI) bleeding. Given advances in small bowel imaging with video capsule endoscopy (VCE), deep enteroscopy, and radiographic imaging, the cause of bleeding in the small bowel can now be identifi ed in most patients. The term small bowel bleeding is therefore proposed as a replacement for the previous classifi cation of obscure GI bleeding (OGIB). We recommend that the term OGIB should be reserved for patients in whom a source of bleeding cannot be identifi ed anywhere in the GI tract. A source of small bowel bleeding should be considered in patients with GI bleeding after performance of a normal upper and lower endoscopic examination. Second-look examinations using upper endoscopy, push enteroscopy, and/or colonoscopy can be performed if indicated before small bowel evaluation. VCE should be considered a fi rst-line procedure for small bowel investigation. Any method of deep enteroscopy can be used when endoscopic evaluation and therapy are required.
    [Show full text]
  • Use of Esophageal Stents After Anastomotic Leakage in Surgery for Gastric Adenocarcinoma Case Report and Review of the Literature
    ISSN: 2574-1241 Volume 5- Issue 4: 2018 DOI: 10.26717/BJSTR.2018.06.001391 Fernando Mendoza-Moreno. Biomed J Sci & Tech Res Case Report Open Access Use of Esophageal Stents After Anastomotic Leakage in Surgery for Gastric Adenocarcinoma Case Report and Review of the Literature Mendoza-Moreno F*1, Díez-Gago MR2, Mínguez-García J1, Enjuto-Martínez DT1,Tallón-Iglesias B1, Solana-Maoño M1 and Argüello-de-Andrés JM1 1Department of General and Digestive Surgery,Sanitas La Moraleja Teaching Hospital, Spain 2Department of Emergency, Príncipe de Asturias Teaching Hospital, Spain Received: July 4, 2018; Published: July 12, 2018 *Corresponding author: Fernando Mendoza-Moreno, Department of General and Digestive Surgery, Sanitas La Moraleja Teaching Hospital, Madrid, Spain Abstract Introduction: Radical gastrectomy is the treatment of choice for the treatment of gastric cancer located in the upper third of stomach or in case of diffuse histology or cells in a signet ring. The worst complication after a radical gastrectomy is the leakage of the esophago-jejunal anastomosis, since it considerably increases the morbidity and mortality of the patient. Case Report: Wedescribe our experience after performing a radical gastrectomy for gastric adenocarcinoma in a patient who developed a leakage of the esophago-jejunal anastomosis in the postoperative period. Although he was reoperated, performing reinforcement of the anastomosis and making a feeding jejunostomy, the dehiscence progressed in the following days until it became almost complete. Then, we proceeded to place a digestive endoprosthesis through gastroscopy with good results, allowing the entire defect to heal and being able to be removed without incidents after 8 weeks.
    [Show full text]
  • Chest Pain, Noncardiac
    Sacramento Heart & Vascular Medical Associates February 18, 2012 500 University Ave. Sacramento, CA 95825 Page 1 916-830-2000 Fax: 916-830-2001 Patient Information For: Only A Test Chest Pain, Noncardiac What is noncardiac chest pain? Chest pain is discomfort that is located between the top of the belly and the base of the neck. Chest pain that is [not] caused by a heart problem is called noncardiac chest pain. Because it is very important to determine the cause, always see your healthcare provider if you have chest pain. How does it occur? The most worrisome causes of chest pain are related to your heart. However, many causes of chest pain are not related to a heart problem. These include: - swallowing disorders such as esophageal spasm, caused by the muscles of the lower esophagus squeezing painfully due to acid reflux or stress - gastrointestinal disorders such as heartburn, which is stomach acid backing up into the esophagus - lung disease such as bronchitis or pneumonia - problems affecting the ribs and chest muscles such as muscle strain or inflammation of the ribs or muscles - anxiety or panic attacks - inflammation of the sack around the heart (pericarditis) or of the lining of the lungs (pleuritis/pleurisy). How is it diagnosed? Keeping track of your chest pain will help your healthcare provider make the diagnosis. Write down: - what the pain feels like, such as stabbing, dull, or burning - when it happens and how long it lasts - where it hurts - what makes it better or worse - any other symptoms, such as nausea, vomiting, sweating, or trouble breathing.
    [Show full text]
  • Stents for the Gastrointestinal Tract and Nutritional Implications
    NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #46 Carol Rees Parrish, R.D., M.S., Series Editor Stents for the Gastrointestinal Tract and Nutritional Implications Michelle Loch Michel Kahaleh Endoscopic stenting of many sites along the gastrointestinal tract is used successfully for palliation of malignant or benign obstructions. These obstructions may be the result of primary gastrointestinal tumors invading the lumen, tumors of another primary site causing external compression or in some instance benign diseases secondary to various inflammatory processes. Stenting of the gastrointestinal tract has been commonly per- formed either by interventional radiologists with the use of fluoroscopy, or by gas- troenterologists endoscopically, with or without fluoroscopic guidance. Their efficacy can be measured by resolution of obstruction or symptom improvement. The current literature shows that endoscopic stenting have acceptable success and complication rates and might be considered as first-line therapy in centers offering expertise in inter- ventional endoscopy. The techniques, efficacy and complication of stenting will be dis- cussed. Nutritional guidelines will also be provided based on our institutions practice. INTRODUCTION most current literature (Table 1) (4–9). Common causes ndoscopy within the last two decades has encom- of stent requirement to preserve nutritional status passed many interventional procedures allowing include esophageal, duodenal, biliary and colonic Ethe treatment of multiple conditions of the upper obstruction;
    [Show full text]